Two recent studies from Dr. Sita Kugel’s lab at Fred Hutch Cancer Center identify a key biological signature that not only ...

The fifth Symposium on Infectious Disease in the Immunocompromised Host convened in Seattle last month. Experts and rising ...

Fred Hutch announces eight recipients of the 2025 Dr. Eddie Méndez Scholar Award, which honors exceptional postdoctoral researchers in the areas of cancer, infectious disease and basic science.

Fred Hutch Cancer Center aims to enroll 200,000 patients over the next 10 years in a new research program called TakePART-NW ...

Thanks to generous support and partnership from Alexandria Real Estate Equities, Inc., Fred Hutch has a new, state-of-the-art learning laboratory where high school and college students who participate ...

Fred Hutch and MSK researchers showed that tumors driven by hiccups in RNA processing can't hid from the immune system. In work published in Cell, the team showed they could isolate T cells that ...

Making precision oncology more precise The team analyzed paraffin-embedded meningioma samples from a collection Holland and his colleagues have amassed to build the field’s largest meningioma dataset ...

Fred Hutch Cancer Center Senior Vice President and Director of the Clinical Research Division Sara Hurvitz, MD, recently received the inaugural Smith Family Endowed Chair in Women’s Health. The new ...

In just 50 years, Fred Hutch grew from a regional cancer center into a world-class biomedical research and clinical care institution known for its expertise in molecular biology, tumor virology and ...

Many cancer drugs work by inhibiting the activity of proteins — the molecules that do most of the work in the cell. But some misbehaving proteins that turn normal cells cancerous are difficult to ...

As part of an international collaboration, Fred Hutch scientists provided structural information that helped reveal how two antibodies protect against severe malaria. The findings, published in the ...